rxstat › Classes › Hormone Antagonists And Related Agents

Hormone Antagonists And Related Agents: shortage status in Canada

6 of the 7 hormone antagonists and related agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Abiraterone Partial shortage 1 of 6 reported products affected · est. return Sep 4, 2026 Anastrozole Partial shortage 5 of 13 reported products affected · est. return Jul 30, 2026 Bicalutamide (Casodex) Partial shortage 1 of 9 reported products affected Letrozole Partial shortage 1 of 12 reported products affected Nilutamide (Anandron) Partial shortage 1 of 1 reported products affected Tamoxifen (Nolvadex-D) Partial shortage 2 of 5 reported products affected Exemestane (Aromasin) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.